Japan pharmaceuticals market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027. The market is expected to grow with the projected cumulative annular growth rate on the account of surging demand for pharmaceutical and pharmaceutical products. Moreover, rising demand for the cheaper healthcare services and products is also driving the growth of the Japan pharmaceuticals market in the upcoming five years. Additionally, emergence of the new technologies, and development of more efficient methods for the pharmaceutical manufacturing is further supporting the growth of the Japan pharmaceuticals market in the next five years. Advanced medicines like genomic medicines, nuclear medication, regenerative medicine etc. are also aiding the growth of the Japan pharmaceuticals market future five years. Recent case of pandemic due to widespread viral infection of COVID-19, also positively impacted the Japan pharmaceuticals market. To fulfill the demand the country is already suffering from a national debt of more than USD10 trillion. With the help of cheap labor and increased production for the pharmaceutical products and drugs the market players may support the future growth of the Japan pharmaceuticals market.
Japan pharmaceuticals market is segmented by drug type, product type, application, distribution channel, competitional landscape, and regional distribution. Based on drug type, the market is further divided into generic drugs and branded drugs. Generic drugs are anticipated to holds the largest revenue shares of the market and assert its dominance over the market segment on the account of increased government support toward production of generic drugs. Moreover, the country is already suffering from the heavy debts due to higher expenses of healthcare sectors. To minimize the healthcare cost, the government is promoting the production and usage of generic drugs over branded drugs. Branded drugs are also expected to register significant growth in the next five years on the account of higher sale prices of the product and increased demand for the pharmaceuticals in the country. Furthermore, rapidly increasing geriatric population is also supporting the growth of the Japan pharmaceuticals market in the forecast period.
Some of the top players in the Japan pharmaceuticals market is Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co., Ltd. (Roche), Sawai Pharmaceutical Co. Ltd., Daiichi Sankyo Company, Limited, Astellas Pharma Inc, Nichi-Iko Pharmaceutical Co Ltd, Towa Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co., Ltd., among others. Major market players are actively dedicated in the research and development of the advanced products such that the consumer’s demand could be fulfilled. Consistent research ensures the future launches for the better products and services. With rapidly surging demand for the advanced products, the new market entrants would be able to establish their brand and thus their market-place. Other strategies include collaborations and partnerships with the pre-existing market players or the research institutes such that government funding can be availed for the product development.
Years considered for this report
Historical YearsFY2017 – FY2020
Base YearFY2021
Estimated YearFY2022
Forecast PeriodFY2023 – FY2027
Objective of the Study
- To analyze the historical growth of the market size of Japan pharmaceuticals market from FY2017 to FY2020.
- To estimate and forecast the market size of Japan pharmaceuticals market from FY2021 to FY2027 and growth rate until FY2027.
- To classify and forecast Japan pharmaceuticals market based on drug type, product type, application, distribution channel, regional distribution, and competitional landscape.
- To identify dominant region or segment in the Japan pharmaceuticals market.
- To identify drivers and challenges for Japan pharmaceuticals market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Japan pharmaceuticals market.
- To identify and analyze the profile of leading players operating in Japan pharmaceuticals market.
- To identify key sustainable strategies adopted by market players in Japan pharmaceuticals market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of Japan
Key Target Audience
- Pharmaceuticals manufacturers, end users, and other stakeholders
- Distributers and suppliers of pharmaceuticals and other stakeholders
- Organizations, forums and alliances related to pharmaceuticals
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
